Frequent mutations in the RPL22 gene and its clinical and functional implications

Gynecologic Oncology

Volumn 128, Issue 3, 2013, Pages 470-474

  Novetsky, Akiva P ^a   Zighelboim, Israel ^a   Thompson Jr , Dominic M ^a   Powell, Matthew A ^a   Mutch, David G ^a   Goodfellow, Paul J ^a  

^a USA   (United States)

Author keywords

Endometrial cancer; Microsatellite instability; RPL22

Indexed keywords

COMPLEMENTARY DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIOID ENDOMETRIAL CANCER; ENDOMETRIUM CANCER; EXON; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RPL22 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE, TUMOR; DNA, COMPLEMENTARY; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; EXONS; FEMALE; HUMANS; MICROSATELLITE INSTABILITY; MOLECULAR SEQUENCE DATA; MUTATION; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; SEQUENCE DELETION;

EID: 84873741277     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.10.026     Document Type: Article

References (26)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 1 Jan 2012 10 29
2. N. Howlader, A. Noone, M. Krapcho, N. Neyman, R. Aminou, and S. Altekruse SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) [Internet] Available from: http://seer.cancer.goc/vsr/1975-2009-pops09
3. S.N. Lewin, T.J. Herzog, N.I. Barrena Medel, I. Deutsch, W.M. Burke, and X. Sun Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer Obstet Gynecol 116 5 Nov 2010 1141 1149
4. The Cancer Genome Atlas (TCGA) Pilot Project [Internet]. cancergenome.nih.gov. [cited 2012 Jun. 13] Available from: http://cancergenome. nih.gov/PublishedContent/Files/pdfs/6.5.2.1-TCGA-Pilot.Project.Brochure.pdf
5. S.J. Anderson, J.P.H. Lauritsen, M.G. Hartman, A.M.D. Foushee, J.M. Lefebvre, and S.A. Shinton Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint Immunity 26 6 Jun 2007 759 772
6. K. Sun, H. Xue, H. Wang, Q. Wang, X.-R. Zuo, and W.-P. Xie The effects of siRNA against RPL22 on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells Int J Mol Med 30 2 Aug 2012 351 357
7. M. Sasaki, K. Kawahara, M. Nishio, K. Mimori, R. Kogo, and K. Hamada Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11 Nat Med 17 8 Aug 2011 944 951
8. R. Gryfe, H. Kim, E.T. Hsieh, M.D. Aronson, E.J. Holowaty, and S.B. Bull Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2 Jan 13 2000 69 77
9. R. Sankila, L.A. Aaltonen, H.J. Järvinen, and J.P. Mecklin Better survival rates in patients with MLH1-associated hereditary colorectal cancer Gastroenterology 110 3 Mar 1996 682 687
10. F.A. Sinicrope, and D.J. Sargent Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications Clin Cancer Res 18 6 Mar 15 2012 1506 1512
11. R.F. Caduff, C.M. Johnston, S.M. Svoboda-Newman, E.L. Poy, S.D. Merajver, and T.S. Frank Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma Am J Pathol 148 5 May 1996 1671 1678
12. Y.F. Wong, T.Y. Ip, T.K.H. Chung, T.H. Cheung, G.M. Hampton, and V.W. Wang Clinical and pathologic significance of microsatellite instability in endometrial cancer Int J Gynecol Cancer 9 5 Sep 1999 406 410
13. J.B. Basil, P.J. Goodfellow, J.S. Rader, D.G. Mutch, and T.J. Herzog Clinical significance of microsatellite instability in endometrial carcinoma Cancer 89 8 Oct 15 2000 1758 1764
14. S. Fiumicino, A. Ercoli, G. Ferrandina, P. Hess, G. Raspaglio, and M. Genuardi Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma J Clin Oncol 19 4 Feb 15 2001 1008 1014
15. G.L. Maxwell, J.I. Risinger, A.A. Alvarez, J.C. Barrett, and A. Berchuck Favorable survival associated with microsatellite instability in endometrioid endometrial cancers Obstet Gynecol 97 3 Mar 2001 417 422
16. D.E. Cohn, W.L. Frankel, K.E. Resnick, V.L. Zanagnolo, L.J. Copeland, and H. Hampel Improved survival with an intact DNA mismatch repair system in endometrial cancer Obstet Gynecol 108 5 Nov 2006 1208 1215
17. D. Black, R.A. Soslow, D.A. Levine, C. Tornos, S.C. Chen, and A.J. Hummer Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma J Clin Oncol 24 11 Apr 10 2006 1745 1753
18. I. Zighelboim, P.J. Goodfellow, F. Gao, R.K. Gibb, M.A. Powell, and J.S. Rader Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type J Clin Oncol 25 15 May 20 2007 2042 2048
19. I. Zighelboim, A.P. Schmidt, F. Gao, P.H. Thaker, M.A. Powell, and J.S. Rader ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes J Clin Oncol 27 19 Jul 1 2009 3091 3096
20. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 3 Feb 11 1988 1215
21. D.K. Lahiri, and J.I. Nurnberger A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acids Res 19 19 Oct 11 1991 5444
22. S.A. Byron, M.G. Gartside, C.L. Wellens, M.A. Mallon, J.B. Keenan, and M.A. Powell Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation Cancer Res 68 17 Sep 1 2008 6902 6907
23. S.B. Dewdney, B.J. Rimel, P.H. Thaker, D.M. Thompson, A. Schmidt, and P. Huettner Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers Clin Cancer Res 17 8 Apr 15 2011 2120 2129
24. J.I. Risinger, K. Hayes, G.L. Maxwell, M.E. Carney, R.K. Dodge, and J.C. Barrett PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics Clin Cancer Res 4 12 Dec 1998 3005 3010
25. A. Janiec-Jankowska, B. Konopka, C. Goluda, and U. Najmoła TP53 mutations in endometrial cancers: relation to PTEN gene defects Int J Gynecol Cancer 20 2 Feb 2010 196 202
26. S.F. Lax, B. Kendall, H. Tashiro, R.J. Slebos, and L. Hedrick The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways Cancer 88 4 Feb 15 2000 814 824